At the same time, Synlait said that it expects its 2021 net profit to be level with or slightly lower than the 2020 profit.
The equity raising is supported by Synlait's cornerstone shareholders Bright Dairy Holding and the a2 Milk Company, with pro rata pre-commitments to take up shares by them and guaranteed allocation amounting to approximately $114m in total which have been excluded from the underwrite. The balance of the equity raising is fully underwritten.
Under the placement, Bright Dairy will be allocated its pro-rata portion of the equity raising to ensure that its 39.01 per cent holding in Synlait does not fall.
Synlait said the new capital would also act to strengthen its balance sheet to provide more financial headroom as it navigates Covid-19, which is having an unpredictable impact on the stability of its current and future earnings.
It expects consumer-packaged infant formula volumes to be lower than 2020, with softer demand in 2021 than previously expected as its key customer - a2 Milk - resets its own inventory levels.
Synlait still expects volumes to increase in the second half of 2021 once stocks have cleared.
However, the company expects its half year 2021 net profit to be "significantly lower" than the 2020 half year result.